Global Companion Diagnostic Tests in Oncology Market Growth (Status and Outlook) 2023-2028

Report ID: 1506692 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Companion Diagnostic Tests in Oncology Market Size 2017-2028
        2.1.2 Companion Diagnostic Tests in Oncology Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Companion Diagnostic Tests in Oncology Segment by Type
        2.2.1 Protein Detection
        2.2.2 DNA Detection
    2.3 Companion Diagnostic Tests in Oncology Market Size by Type
        2.3.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    2.4 Companion Diagnostic Tests in Oncology Segment by Application
        2.4.1 Pharmaceutical & Biotechnology Companies
        2.4.2 Medical Device Companies
        2.4.3 Research Institutes
        2.4.4 Others
    2.5 Companion Diagnostic Tests in Oncology Market Size by Application
        2.5.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
3 Companion Diagnostic Tests in Oncology Market Size by Player
    3.1 Companion Diagnostic Tests in Oncology Market Size Market Share by Players
        3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Players (2020-2022)
        3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2020-2022)
    3.2 Global Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Companion Diagnostic Tests in Oncology by Regions
    4.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2017-2022)
    4.2 Americas Companion Diagnostic Tests in Oncology Market Size Growth (2017-2022)
    4.3 APAC Companion Diagnostic Tests in Oncology Market Size Growth (2017-2022)
    4.4 Europe Companion Diagnostic Tests in Oncology Market Size Growth (2017-2022)
    4.5 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022)
    5.2 Americas Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022)
    5.3 Americas Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Companion Diagnostic Tests in Oncology Market Size by Region (2017-2022)
    6.2 APAC Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022)
    6.3 APAC Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Companion Diagnostic Tests in Oncology by Country (2017-2022)
    7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022)
    7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Companion Diagnostic Tests in Oncology by Region (2017-2022)
    8.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022)
    8.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Companion Diagnostic Tests in Oncology Market Forecast
    10.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2023-2028)
        10.1.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2023-2028)
        10.1.2 Americas Companion Diagnostic Tests in Oncology Forecast
        10.1.3 APAC Companion Diagnostic Tests in Oncology Forecast
        10.1.4 Europe Companion Diagnostic Tests in Oncology Forecast
        10.1.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast
    10.2 Americas Companion Diagnostic Tests in Oncology Forecast by Country (2023-2028)
        10.2.1 United States Companion Diagnostic Tests in Oncology Market Forecast
        10.2.2 Canada Companion Diagnostic Tests in Oncology Market Forecast
        10.2.3 Mexico Companion Diagnostic Tests in Oncology Market Forecast
        10.2.4 Brazil Companion Diagnostic Tests in Oncology Market Forecast
    10.3 APAC Companion Diagnostic Tests in Oncology Forecast by Region (2023-2028)
        10.3.1 China Companion Diagnostic Tests in Oncology Market Forecast
        10.3.2 Japan Companion Diagnostic Tests in Oncology Market Forecast
        10.3.3 Korea Companion Diagnostic Tests in Oncology Market Forecast
        10.3.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Forecast
        10.3.5 India Companion Diagnostic Tests in Oncology Market Forecast
        10.3.6 Australia Companion Diagnostic Tests in Oncology Market Forecast
    10.4 Europe Companion Diagnostic Tests in Oncology Forecast by Country (2023-2028)
        10.4.1 Germany Companion Diagnostic Tests in Oncology Market Forecast
        10.4.2 France Companion Diagnostic Tests in Oncology Market Forecast
        10.4.3 UK Companion Diagnostic Tests in Oncology Market Forecast
        10.4.4 Italy Companion Diagnostic Tests in Oncology Market Forecast
        10.4.5 Russia Companion Diagnostic Tests in Oncology Market Forecast
    10.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast by Region (2023-2028)
        10.5.1 Egypt Companion Diagnostic Tests in Oncology Market Forecast
        10.5.2 South Africa Companion Diagnostic Tests in Oncology Market Forecast
        10.5.3 Israel Companion Diagnostic Tests in Oncology Market Forecast
        10.5.4 Turkey Companion Diagnostic Tests in Oncology Market Forecast
        10.5.5 GCC Countries Companion Diagnostic Tests in Oncology Market Forecast
    10.6 Global Companion Diagnostic Tests in Oncology Forecast by Type (2023-2028)
    10.7 Global Companion Diagnostic Tests in Oncology Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Abbott
        11.1.1 Abbott Company Information
        11.1.2 Abbott Companion Diagnostic Tests in Oncology Product Offered
        11.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Abbott Main Business Overview
        11.1.5 Abbott Latest Developments
    11.2 Roche
        11.2.1 Roche Company Information
        11.2.2 Roche Companion Diagnostic Tests in Oncology Product Offered
        11.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Roche Main Business Overview
        11.2.5 Roche Latest Developments
    11.3 Genomic Health
        11.3.1 Genomic Health Company Information
        11.3.2 Genomic Health Companion Diagnostic Tests in Oncology Product Offered
        11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Genomic Health Main Business Overview
        11.3.5 Genomic Health Latest Developments
    11.4 QIAGEN
        11.4.1 QIAGEN Company Information
        11.4.2 QIAGEN Companion Diagnostic Tests in Oncology Product Offered
        11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 QIAGEN Main Business Overview
        11.4.5 QIAGEN Latest Developments
    11.5 Agilent
        11.5.1 Agilent Company Information
        11.5.2 Agilent Companion Diagnostic Tests in Oncology Product Offered
        11.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Agilent Main Business Overview
        11.5.5 Agilent Latest Developments
    11.6 Agendia
        11.6.1 Agendia Company Information
        11.6.2 Agendia Companion Diagnostic Tests in Oncology Product Offered
        11.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Agendia Main Business Overview
        11.6.5 Agendia Latest Developments
    11.7 BioMerieux
        11.7.1 BioMerieux Company Information
        11.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Offered
        11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 BioMerieux Main Business Overview
        11.7.5 BioMerieux Latest Developments
    11.8 Illumina
        11.8.1 Illumina Company Information
        11.8.2 Illumina Companion Diagnostic Tests in Oncology Product Offered
        11.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Illumina Main Business Overview
        11.8.5 Illumina Latest Developments
    11.9 Siemens Healthcare
        11.9.1 Siemens Healthcare Company Information
        11.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
        11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Siemens Healthcare Main Business Overview
        11.9.5 Siemens Healthcare Latest Developments
    11.10 Thermo Fisher
        11.10.1 Thermo Fisher Company Information
        11.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
        11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Thermo Fisher Main Business Overview
        11.10.5 Thermo Fisher Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Companion Diagnostic Tests in Oncology Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Protein Detection
    Table 3. Major Players of DNA Detection
    Table 4. Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    Table 7. Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
    Table 10. Global Companion Diagnostic Tests in Oncology Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player (2020-2022)
    Table 12. Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
    Table 13. Companion Diagnostic Tests in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Companion Diagnostic Tests in Oncology Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2017-2022)
    Table 20. Americas Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    Table 22. Americas Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
    Table 24. APAC Companion Diagnostic Tests in Oncology Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2017-2022)
    Table 26. APAC Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    Table 28. APAC Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
    Table 30. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2017-2022)
    Table 32. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Companion Diagnostic Tests in Oncology
    Table 43. Key Market Challenges & Risks of Companion Diagnostic Tests in Oncology
    Table 44. Key Industry Trends of Companion Diagnostic Tests in Oncology
    Table 45. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Abbott Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 52. Abbott Companion Diagnostic Tests in Oncology Product Offered
    Table 53. Abbott Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Abbott Main Business
    Table 55. Abbott Latest Developments
    Table 56. Roche Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 57. Roche Companion Diagnostic Tests in Oncology Product Offered
    Table 58. Roche Main Business
    Table 59. Roche Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Roche Latest Developments
    Table 61. Genomic Health Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 62. Genomic Health Companion Diagnostic Tests in Oncology Product Offered
    Table 63. Genomic Health Main Business
    Table 64. Genomic Health Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Genomic Health Latest Developments
    Table 66. QIAGEN Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 67. QIAGEN Companion Diagnostic Tests in Oncology Product Offered
    Table 68. QIAGEN Main Business
    Table 69. QIAGEN Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. QIAGEN Latest Developments
    Table 71. Agilent Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 72. Agilent Companion Diagnostic Tests in Oncology Product Offered
    Table 73. Agilent Main Business
    Table 74. Agilent Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Agilent Latest Developments
    Table 76. Agendia Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 77. Agendia Companion Diagnostic Tests in Oncology Product Offered
    Table 78. Agendia Main Business
    Table 79. Agendia Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Agendia Latest Developments
    Table 81. BioMerieux Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 82. BioMerieux Companion Diagnostic Tests in Oncology Product Offered
    Table 83. BioMerieux Main Business
    Table 84. BioMerieux Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. BioMerieux Latest Developments
    Table 86. Illumina Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 87. Illumina Companion Diagnostic Tests in Oncology Product Offered
    Table 88. Illumina Main Business
    Table 89. Illumina Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Illumina Latest Developments
    Table 91. Siemens Healthcare Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 92. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
    Table 93. Siemens Healthcare Main Business
    Table 94. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Siemens Healthcare Latest Developments
    Table 96. Thermo Fisher Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
    Table 97. Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
    Table 98. Thermo Fisher Main Business
    Table 99. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Thermo Fisher Latest Developments
List of Figures
    Figure 1. Companion Diagnostic Tests in Oncology Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2021
    Figure 7. Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies
    Figure 8. Global Companion Diagnostic Tests in Oncology Market: Pharmaceutical & Biotechnology Companies (2017-2022) & ($ Millions)
    Figure 9. Companion Diagnostic Tests in Oncology in Medical Device Companies
    Figure 10. Global Companion Diagnostic Tests in Oncology Market: Medical Device Companies (2017-2022) & ($ Millions)
    Figure 11. Companion Diagnostic Tests in Oncology in Research Institutes
    Figure 12. Global Companion Diagnostic Tests in Oncology Market: Research Institutes (2017-2022) & ($ Millions)
    Figure 13. Companion Diagnostic Tests in Oncology in Others
    Figure 14. Global Companion Diagnostic Tests in Oncology Market: Others (2017-2022) & ($ Millions)
    Figure 15. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2021
    Figure 16. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player in 2021
    Figure 17. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2017-2022)
    Figure 18. Americas Companion Diagnostic Tests in Oncology Market Size 2017-2022 ($ Millions)
    Figure 19. APAC Companion Diagnostic Tests in Oncology Market Size 2017-2022 ($ Millions)
    Figure 20. Europe Companion Diagnostic Tests in Oncology Market Size 2017-2022 ($ Millions)
    Figure 21. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2017-2022 ($ Millions)
    Figure 22. Americas Companion Diagnostic Tests in Oncology Value Market Share by Country in 2021
    Figure 23. Americas Companion Diagnostic Tests in Oncology Consumption Market Share by Type in 2021
    Figure 24. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2021
    Figure 25. United States Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Canada Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 27. Mexico Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Brazil Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 29. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region in 2021
    Figure 30. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2021
    Figure 31. China Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Japan Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Korea Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Southeast Asia Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 35. India Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Australia Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country in 2021
    Figure 38. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2021
    Figure 39. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2021
    Figure 40. Germany Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 41. France Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 42. UK Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Italy Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Russia Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region in 2021
    Figure 46. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2021
    Figure 47. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2021
    Figure 48. Egypt Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 49. South Africa Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 50. Israel Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Turkey Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 52. GCC Country Companion Diagnostic Tests in Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Americas Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 54. APAC Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 55. Europe Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 56. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 57. United States Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 58. Canada Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 59. Mexico Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 60. Brazil Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 61. China Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 62. Japan Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 63. Korea Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 64. Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 65. India Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 66. Australia Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 67. Germany Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 68. France Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 69. UK Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 70. Italy Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 71. Russia Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 72. Spain Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 73. Egypt Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 74. South Africa Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 75. Israel Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 76. Turkey Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
    Figure 77. GCC Countries Companion Diagnostic Tests in Oncology Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Companion Diagnostic Tests in Oncology Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Companion Diagnostic Tests in Oncology Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Companion Diagnostic Tests in Oncology Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports